Interferon-gamma and cancer immunoediting. - Wikidata - awgldk - TriplyDB

Interferon-gamma and cancer immunoediting.

Interferon-gamma and cancer immunoediting.

http://www.wikidata.org/entity/Q36232730

about

Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity A functional role for Nlrp6 in intestinal inflammation and tumorigenesis Different regulation of MHC class I antigen processing components in human tumors.Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.A high-content screening (HCS) assay for the identification of chemical inducers of PML oncogenic domains (PODs).Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time.Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma Interferon γ limits the effectiveness of melanoma peptide vaccines.Dual roles of immune cells and their factors in cancer development and progression The immunomodulating roles of glycoproteins in epithelial ovarian cancer.The role of Tyk2 in regulation of breast cancer growth.NK cells require IL-28R for optimal in vivo activity IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses.CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.Immune resistance orchestrated by the tumor microenvironment.Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.Macrophages define the invasive microenvironment in breast cancer.Tumor immunoediting and immunosculpting pathways to cancer progression.Chemokines: novel targets for breast cancer metastasis Why do patients with low-grade soft tissue sarcoma die?B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.Cytokines in cancer immunotherapy.Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer.Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects NF-kappaB fans the flames of lung carcinogenesis.IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors.Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?Cancer immunoediting in malignant glioma.Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.Promising new therapies in advanced pancreatic adenocarcinomas.Cancer immunoediting of the NK group 2D ligand H60a.B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.Cytokine production suppression by culture supernatant of B16F10 cells and amelioration by Ganoderma lucidum polysaccharides in activated lymphocytes.

P2860

Q26862947-2B653E8E-84CC-47CE-9B4D-C56DEB652263 Q28508154-407A49A7-6E3C-487B-980D-A7D1DAC20424 Q30319116-8AC47BC6-0D5A-48AE-966E-A0F5F8350224 Q30479486-FE6BDA76-4766-4D0C-BD46-317D1983BC8C Q30850932-A9C8A74B-F92F-42D5-B693-91A16AC4CE59 Q33793019-03150855-1F5A-425B-8441-2CD73451B47B Q33812026-2E1E8CBB-7A1F-4154-BF31-688CDFCA57BE Q34445730-B6D86A36-A9EC-4BF4-8C53-4404B3307FBB Q34526425-37C4BF06-ECC0-4DAC-A6C3-0D6A1334ED89 Q34568835-5F874B6E-4AC3-4FF4-9D27-DBC5B6838AA2 Q35022538-2B97F0B4-67D2-434B-B90E-9DF4A65CBC16 Q35077893-7FE83FA5-FA3B-4872-BBF8-E8A2D0044EF5 Q35214992-783AFE59-C910-489E-B3BF-FEB05B5C3732 Q35590214-375E9F4C-E0A3-4CE9-A151-FEB3C50DEE06 Q35621594-8E661F5F-63D1-451B-A402-75CC353950A8 Q35676736-C634FF44-7690-4BE7-8941-7091F98BF952 Q36245106-E0E18B4F-B6E3-4579-9579-E50F63B9139E Q36288241-6DF14A8A-9286-42ED-9210-C1CF91B4898E Q36377233-40D85DEB-8E04-47A7-A8F5-372831691B54 Q36593747-3E13C42D-34B5-4D64-9074-E9AB9AF581A8 Q36824936-C7CAD4E3-26E4-4E14-AEBC-CE66A79E516A Q36838542-09D3EBB0-2771-490E-A371-95BECF217E86 Q36896195-8D50F29E-72A5-428D-9D17-482386E776D0 Q36918688-DA5950E6-3799-4842-B36C-D155A12E6501 Q37019537-51917978-F361-4406-9FBA-03C31C076CE0 Q37058863-6FA1D75F-7D93-4CBB-A3D9-40FDBDCA72B6 Q37062216-0F834B29-10F3-49A8-8EC9-7033F4BDDBAD Q37148152-44E7A534-4BF6-4E59-9F20-315ED59EBE4D Q37440871-DAA1B4E9-9208-4472-8BA0-0A355E977713 Q37461129-AE101A31-C46B-449E-A3E5-8B1B5CE9DD82 Q37721657-41C6D302-614B-4B17-AE47-70F92500F1EE Q37937750-40B143DD-A816-4CE8-BD6E-C34F609E13AF Q37974301-129EAB75-3139-4599-94A7-F4BD501963C1 Q37986999-EE9973E3-C58A-4E52-AB49-A9B22C1F94BD Q38091116-E652C4DA-3DC0-4A80-A0AE-CDE46E3BCA3A Q38296663-E7AF847D-A7EC-46DA-9FCA-F25B9889E12F Q38546761-A7501AC3-6FEB-45D2-A1E2-D65AB63CB12B Q38769013-070BAEF1-BB64-4358-B2F9-514C6F75974E Q38791826-BFF4A9A4-F8F2-4589-A44E-DD6C079283F7 Q38920354-513CD065-03E6-4127-A4EB-E679A797E10F

P2860

Interferon-gamma and cancer immunoediting.

http://www.wikidata.org/entity/Q36232730

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Interferon-gamma and cancer immunoediting.

@ast

Interferon-gamma and cancer immunoediting.

@en

type

label

Interferon-gamma and cancer immunoediting.

@ast

Interferon-gamma and cancer immunoediting.

@en

prefLabel

Interferon-gamma and cancer immunoediting.

@ast

Interferon-gamma and cancer immunoediting.

@en

P1433

Q36232730-8406698C-0225-425F-9F0A-06D128450072

P1476

Q36232730-BC5A5AA9-355C-46A8-ADCD-B07B4099797F

P2093

Q36232730-25DDDBCE-F255-4B0E-BE34-A2BE8714EBB0

Q36232730-2FD882B3-0FA4-44ED-90B9-92930BEE8699

Q36232730-30EBCAB0-CA8D-47CB-A064-CD8B3C0966E9

Q36232730-63D15CF1-7941-4D15-94C2-DD867B7666DC

Q36232730-66931410-F31B-49A3-963C-206EBB35954B

Q36232730-751E3C02-502B-4A95-AEA3-447358E9902F

Q36232730-ADB69884-A1D7-48F4-94A5-4DE37288B683

Q36232730-B246D0E7-471E-4B78-AA65-1E83F73749CB

Q36232730-BFEE6D8B-ED5B-42B6-A6A0-73BDAC3B048D

Q36232730-F32ABEA4-BEF0-448F-8EBF-BEA29C0C92E7

P2888

Q36232730-E001DB0D-03B6-4C7B-900B-0980D560CA9E

P304

Q36232730-7D2B7783-9F5B-4B6E-8BD4-7B6B59B134AF

P31

Q36232730-AAC2818D-5D30-4DB5-B87D-3C786106B1CD

P356

Q36232730-8876A22F-A25E-462A-AF89-78691A48399E

P433

Q36232730-1E4639A8-D494-4E9A-954F-E2CBA8B345DB

P478

Q36232730-7740E008-6B42-4B7E-9B51-0FC047E96219

P50

Q36232730-CDB07516-61E0-4E3E-927A-DBB2E9517B8F

P577

Q36232730-F386BBB2-94CD-4F3C-BA16-7D7F18A2B312

P6179

Q36232730-6E54AC2E-1A95-4BB6-A4C5-E7A364876FB2

P698

Q36232730-01E79ECE-DCD4-45B9-B02E-987F7557F783

P356

P1433

Immunologic Research

P1476

Interferon-gamma and cancer immunoediting.

@en

P2093

Allen T Bruce

http://www.w3.org/2001/XMLSchema#string

Catherine Koebel

http://www.w3.org/2001/XMLSchema#string

Gavin P Dunn

http://www.w3.org/2001/XMLSchema#string

Hiroaki Ikeda

http://www.w3.org/2001/XMLSchema#string

Jack Bui

http://www.w3.org/2001/XMLSchema#string

Kathleen C F Sheehan

http://www.w3.org/2001/XMLSchema#string

Mark Diamond

http://www.w3.org/2001/XMLSchema#string

Ravi Uppaluri

http://www.w3.org/2001/XMLSchema#string

Robert D Schreiber

http://www.w3.org/2001/XMLSchema#string

Ruby Chan

http://www.w3.org/2001/XMLSchema#string

P2888

P304

231-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1385/IR:32:1-3:231

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

James Michael White

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015039980

http://www.w3.org/2001/XMLSchema#string

P698

16106075

http://www.w3.org/2001/XMLSchema#string